Anexate, Injektionslösung

7680482800133 CH-48280 Injektionslösung
Anexate, Injektionslösung
Anexate, Injektionslösung
Anexate, Injektionslösung
1 / 3
google

Article details

Package size
5 x 5 mL
Selling units
25
Measure
Ampulle(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
12/02/2025
Summary of Product Characteristics
Français
12/02/2025
Summary of Product Characteristics
Italien
12/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
0.1 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.67 MG Substance HBESI

Authorization holder

Cheplapharm Schweiz GmbH

4102 Binningen

Authorization information

Swissmedic authorization number
48280
Drug name
Anexate, Injektionslösung
Galenic form
LSPA
ATC Code
V03AB25
Authorization status
Z
Dispensing category
B
First authorization
30/12/1986
Authorization expiration date
31/12/9999
IT Number
15.01.0.
Domain
Human medicine
Field of application
Benzodiazepin-Antagonist

Package details

Description (FR)
ANEXATE sol inj 0.5 mg/5ml 5 amp 5 ml
Description (DE)
ANEXATE Inj Lös 0.5 mg/5ml 5 Amp 5 ml
Market launch
30/12/1986
Narcotic (BTM)
No